Literature DB >> 30047375

Outbreak of Ebola virus disease in the Democratic Republic of the Congo, April-May, 2018: an epidemiological study.

.   

Abstract

BACKGROUND: On May 8, 2018, the Government of the Democratic Republic of the Congo reported an outbreak of Ebola virus disease in Équateur Province in the northwest of the country. The remoteness of most affected communities and the involvement of an urban centre connected to the capital city and neighbouring countries makes this outbreak the most complex and high risk ever experienced by the Democratic Republic of the Congo. We provide early epidemiological information arising from the ongoing investigation of this outbreak.
METHODS: We classified cases as suspected, probable, or confirmed using national case definitions of the Democratic Republic of the Congo Ministère de la Santé Publique. We investigated all cases to obtain demographic characteristics, determine possible exposures, describe signs and symptoms, and identify contacts to be followed up for 21 days. We also estimated the reproduction number and projected number of cases for the 4-week period from May 25, to June 21, 2018.
FINDINGS: As of May 30, 2018, 50 cases (37 confirmed, 13 probable) of Zaire ebolavirus were reported in the Democratic Republic of the Congo. 21 (42%) were reported in Bikoro, 25 (50%) in Iboko, and four (8%) in Wangata health zones. Wangata is part of Mbandaka, the urban capital of Équateur Province, which is connected to major national and international transport routes. By May 30, 2018, 25 deaths from Ebola virus disease had been reported, with a case fatality ratio of 56% (95% CI 39-72) after adjustment for censoring. This case fatality ratio is consistent with estimates for the 2014-16 west African Ebola virus disease epidemic (p=0·427). The median age of people with confirmed or probable infection was 40 years (range 8-80) and 30 (60%) were male. The most commonly reported signs and symptoms in people with confirmed or probable Ebola virus disease were fever (40 [95%] of 42 cases), intense general fatigue (37 [90%] of 41 cases), and loss of appetite (37 [90%] of 41 cases). Gastrointestinal symptoms were frequently reported, and 14 (33%) of 43 people reported haemorrhagic signs. Time from illness onset and hospitalisation to sample testing decreased over time. By May 30, 2018, 1458 contacts had been identified, of which 746 (51%) remained under active follow-up. The estimated reproduction number was 1·03 (95% credible interval 0·83-1·37) and the cumulative case incidence for the outbreak by June 21, 2018, is projected to be 78 confirmed cases (37-281), assuming heterogeneous transmissibility.
INTERPRETATION: The ongoing Ebola virus outbreak in the Democratic Republic of the Congo has similar epidemiological features to previous Ebola virus disease outbreaks. Early detection, rapid patient isolation, contact tracing, and the ongoing vaccination programme should sufficiently control the outbreak. The forecast of the number of cases does not exceed the current capacity to respond if the epidemiological situation does not change. The information presented, although preliminary, has been essential in guiding the ongoing investigation and response to this outbreak. FUNDING: None.
Copyright © 2018 World Health Organization. Published by Elsevier Ltd. All rights reserved. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30047375     DOI: 10.1016/S0140-6736(18)31387-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  33 in total

1.  COVID-19 in Japan, January-March 2020: insights from the first three months of the epidemic.

Authors:  Natsuko Imai; Katy A M Gaythorpe; Sangeeta Bhatia; Tara D Mangal; Gina Cuomo-Dannenburg; H Juliette T Unwin; Elita Jauneikaite; Neil M Ferguson
Journal:  BMC Infect Dis       Date:  2022-05-25       Impact factor: 3.667

2.  Zaire ebolavirus surveillance near the Bikoro region of the Democratic Republic of the Congo during the 2018 outbreak reveals presence of seropositive bats.

Authors:  Stephanie N Seifert; Robert J Fischer; Eeva Kuisma; Cynthia Badzi Nkoua; Gerard Bounga; Marc-Joël Akongo; Jonathan E Schulz; Beatriz Escudero-Pérez; Beal-Junior Akoundzie; Vishnou Reize Bani Ampiri; Ankara Dieudonne; Ghislain Dzeret Indolo; Serge D Kaba; Igor Louzolo; Lucette Nathalie Macosso; Yanne Mavoungou; Valchy Bel-Bebi Miegakanda; Rock Aimé Nina; Kevin Tolovou Samabide; Alain I Ondzie; Francine Ntoumi; César Muñoz-Fontela; Jean-Vivien Mombouli; Sarah H Olson; Chris Walzer; Fabien Roch Niama; Vincent J Munster
Journal:  PLoS Negl Trop Dis       Date:  2022-06-22

3.  Impact of a free care policy on the utilisation of health services during an Ebola outbreak in the Democratic Republic of Congo: an interrupted time-series analysis.

Authors:  Yuen W Hung; Michael R Law; Lucy Cheng; Sharon Abramowitz; Lys Alcayna-Stevens; Grégoire Lurton; Serge Manitu Mayaka; Romain Olekhnovitch; Gabriel Kyomba; Hinda Ruton; Sylvain Yuma Ramazani; Karen A Grépin
Journal:  BMJ Glob Health       Date:  2020-07

Review 4.  Emerging infectious diseases in Africa in the 21st century.

Authors:  F Fenollar; O Mediannikov
Journal:  New Microbes New Infect       Date:  2018-09-21

5.  Phylodynamic Analysis of Ebola Virus Disease Transmission in Sierra Leone.

Authors:  Petrus Jansen van Vuren; Jason T Ladner; Antoinette A Grobbelaar; Michael R Wiley; Sean Lovett; Mushal Allam; Arshad Ismail; Chantel le Roux; Jacqueline Weyer; Naazneen Moolla; Nadia Storm; Joe Kgaladi; Mariano Sanchez-Lockhart; Ousman Conteh; Gustavo Palacios; Janusz T Paweska
Journal:  Viruses       Date:  2019-01-16       Impact factor: 5.048

Review 6.  Outbreak analytics: a developing data science for informing the response to emerging pathogens.

Authors:  Jonathan A Polonsky; Amrish Baidjoe; Zhian N Kamvar; Anne Cori; Kara Durski; W John Edmunds; Rosalind M Eggo; Sebastian Funk; Laurent Kaiser; Patrick Keating; Olivier le Polain de Waroux; Michael Marks; Paula Moraga; Oliver Morgan; Pierre Nouvellet; Ruwan Ratnayake; Chrissy H Roberts; Jimmy Whitworth; Thibaut Jombart
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-07-08       Impact factor: 6.237

7.  Involvement of Surfactant Protein D in Ebola Virus Infection Enhancement via Glycoprotein Interaction.

Authors:  Anne-Laure Favier; Olivier Reynard; Evelyne Gout; Martin van Eijk; Henk P Haagsman; Erika Crouch; Viktor Volchkov; Christophe Peyrefitte; Nicole M Thielens
Journal:  Viruses       Date:  2018-12-26       Impact factor: 5.048

8.  Machine-learning Prognostic Models from the 2014-16 Ebola Outbreak: Data-harmonization Challenges, Validation Strategies, and mHealth Applications.

Authors:  Andres Colubri; Mary-Anne Hartley; Matthew Siakor; Vanessa Wolfman; August Felix; Tom Sesay; Jeffrey G Shaffer; Robert F Garry; Donald S Grant; Adam C Levine; Pardis C Sabeti
Journal:  EClinicalMedicine       Date:  2019-06-22

9.  The monetary value of human lives lost through Ebola virus disease in the Democratic Republic of Congo in 2019.

Authors:  Joses M Kirigia; Rose Nabi Deborah Karimi Muthuri; Newton Gitonga Muthuri
Journal:  BMC Public Health       Date:  2019-09-03       Impact factor: 3.295

10.  Rigorous surveillance is necessary for high confidence in end-of-outbreak declarations for Ebola and other infectious diseases.

Authors:  Robin N Thompson; Oliver W Morgan; Katri Jalava
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-07-08       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.